A Metabolomic Analysis of Cirrhotic Ascites

Ascites is a common complication of decompensated liver cirrhosis, and yet relatively little is known about its biochemical composition. We conducted two metabolomic investigations, comparing the profile of ascites from 33 cirrhotic patients and postoperative peritoneal drainage fluid from 33 surgical patients (Experiment 1). The profile of paired ascites and plasma was also compared in 17 cirrhotic patients (Experiment 2). Gas chromatography–mass spectrometry-based metabolomics identified 29 metabolites that significantly characterized ascites fluid, whether postoperative drainage fluid or plasma were used as controls. Ten elevated amino acids (glutamine, proline, histidine, tyrosine, glycine, valine, threonine, methionine, lysine, phenylalanine) and seven diminished lipids (laurate, myristate, palmitate, oleate, vaccenate, stearate, cholesterol) largely comprised the cirrhotic ascites metabolomic phenotype that differed significantly (adjusted p < 0.002 to 0.03) from peritoneal drainage fluid or plasma. The pattern of upregulated amino acids in cirrhotic ascites did not indicate albumin proteolysis by peritoneal bacteria. Bidirectional clustering showed that the more severe the cirrhosis, the lower the lipid concentration in ascitic fluid. The metabolomic compartment of ascites in patients with decompensated cirrhosis is characterized by increased amino acids and decreased lipids. These novel findings have potential relevance for diagnostic purposes.

[1]  A A Spector,et al.  Fatty acid binding to plasma albumin. , 1975, Journal of lipid research.

[2]  O. G. Lien,et al.  Identification of alpha-aminobutyric acid enzymatically formed from threonine. , 1953, The Journal of biological chemistry.

[3]  K. Kawai,et al.  Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro. , 2005, Biological & pharmaceutical bulletin.

[4]  E. Moore,et al.  Metabolomics of trauma-associated death: shared and fluid-specific features of human plasma vs lymph. , 2016, Blood transfusion = Trasfusione del sangue.

[5]  J. Henderson,et al.  Analysis of Twenty‐three Plasma Proteins in Ascites The Depletion of Fibrinogen and Plasminogen , 1980, Annals of surgery.

[6]  N. Subbarao,et al.  Ligand binding strategies of human serum albumin: how can the cargo be utilized? , 2010, Chirality.

[7]  J. Idle,et al.  Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection , 2015, Journal of viral hepatitis.

[8]  S. Møller EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. , 2010, Journal of hepatology.

[9]  R. Roy,et al.  1H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods , 2008, NMR in biomedicine.

[10]  Z. Bhujwalla,et al.  Metabolomic characterization of experimental ovarian cancer ascitic fluid , 2017, Metabolomics.

[11]  Caroline H. Johnson,et al.  Metabolomics: beyond biomarkers and towards mechanisms , 2016, Nature Reviews Molecular Cell Biology.

[12]  Kai Zhang,et al.  An herbal-compound-based combination therapy that relieves cirrhotic ascites by affecting the L-arginine/nitric oxide pathway: A metabolomics-based systematic study. , 2019, Journal of ethnopharmacology.

[13]  Thorsten Dickhaus,et al.  Simultaneous Statistical Inference , 2014, Springer Berlin Heidelberg.

[14]  V. Govorun,et al.  Proteome–Metabolome Profiling of Ovarian Cancer Ascites Reveals Novel Components Involved in Intercellular Communication* , 2014, Molecular & Cellular Proteomics.

[15]  S. Curry,et al.  Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. , 2001, Journal of molecular biology.

[16]  S. Imbeaud,et al.  Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification , 2013, Hepatology.

[17]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[18]  Y. Muto,et al.  Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication , 2008, Gastroenterologia Japonica.

[19]  A. Gerbes,et al.  Pathophysiology of elevated ascites fluid cholesterol in malignant ascites. Increased ascites to serum relation of proteins and lipoproteins in patients with peritoneal carcinomatosis as compared to patients with cirrhosis of the liver. , 1992, Journal of hepatology.

[20]  H. Liebich,et al.  Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. , 1984, Journal of chromatography.

[21]  Yuyin Zhou,et al.  Mass isotopomer-guided decluttering of metabolomic data to visualize endogenous biomarkers of drug toxicity. , 2018, Biochemical pharmacology.

[22]  G. Mustafa,et al.  HYPOALBUMINEMIA; , 2012, The Professional Medical Journal.

[23]  Igor V. Tetko,et al.  Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices , 2001, J. Chem. Inf. Comput. Sci..

[24]  J. Idle,et al.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy , 2020, Metabolites.

[25]  R. Subramanyam,et al.  Binding studies of L-3,4-dihydroxyphenylalanine with human serum albumin. , 2014, Molecular bioSystems.

[26]  Oliver Fiehn,et al.  Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research , 2009, Metabolomics.

[27]  D. Cistola,et al.  Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study. , 1991, The Journal of clinical investigation.

[28]  G. J. Vusse Albumin as Fatty Acid Transporter , 2008 .

[29]  Enzo Terreno,et al.  The extraordinary ligand binding properties of human serum albumin , 2005, IUBMB life.

[30]  Y. Iwakiri,et al.  The lymphatic vascular system in liver diseases: its role in ascites formation , 2013, Clinical and molecular hepatology.

[31]  Chenghai Liu,et al.  Serum Metabolomic Characteristics of Patients with Liver Cirrhotic Ascites , 2015, Integrative Medicine International.

[32]  S. McPherson,et al.  Management of decompensated cirrhosis , 2018, Clinical medicine.

[33]  T. Key,et al.  Plasma concentrations and intakes of amino acids in male meat-eaters, fish-eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort , 2015, European Journal of Clinical Nutrition.

[34]  G. Hedenborg,et al.  Bile constituents in ascitic fluid. , 1988, Scandinavian journal of clinical and laboratory investigation.

[35]  M. Otagiri,et al.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. , 2002, Biological & pharmaceutical bulletin.

[36]  J. Hirschberger,et al.  Glutamine and Glutamate in Ascitic Fluid of Dogs , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[37]  R. Pollitt,et al.  The occurrence of (S)-3,4-dihydroxybutyrate in human blood and urine. , 1975, Biochemical medicine.

[38]  G. Mingrone,et al.  Free fatty acid analysis in ascitic fluid improves diagnosis in malignant abdominal tumors. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[39]  J. Idle,et al.  Metabolic Rewiring and the Characterization of Oncometabolites , 2021, Cancers.

[40]  E. Dudley,et al.  Metabolomics and Biomarker Discovery. , 2019, Advances in experimental medicine and biology.

[41]  I. Spak On the clinical value of chemical analysis of ascites. A study of the main proteins and some enzymes in ascites of differing etiology. , 1960, Acta chirurgica Scandinavica. Supplementum.

[42]  G. J. van der Vusse Albumin as fatty acid transporter. , 2009, Drug metabolism and pharmacokinetics.

[43]  J. Idle,et al.  The metabolomic profile of gamma-irradiated human hepatoma and muscle cells reveals metabolic changes consistent with the Warburg effect , 2016, PeerJ.

[44]  B. Meloun,et al.  Complete amino acid sequence of human serum albumin , 1975, FEBS letters.

[45]  J. Nicholson,et al.  1H NMR studies on protein binding of histidine, tyrosine and phenylalanine in blood plasma , 1989, NMR in biomedicine.

[46]  J. Idle,et al.  (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia , 2020, Cancers.

[47]  B. Runyon Management of adult patients with ascites due to cirrhosis: An update , 2009, Hepatology.

[48]  A. Fassina,et al.  1H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites , 2020, Pleura and peritoneum.

[49]  P. Reeds,et al.  Dispensable and indispensable amino acids for humans. , 2000, The Journal of nutrition.

[50]  Rachit Jain,et al.  Establishing a novel biosynthetic pathway for the production of 3,4-dihydroxybutyric acid from xylose in Escherichia coli. , 2017, Metabolic engineering.

[51]  J. Idle,et al.  Metabolomic insights into the mode of action of natural products in the treatment of liver disease. , 2020, Biochemical pharmacology.

[52]  J. Ward,et al.  A 1-step microplate method for assessing the substrate range of l-α-amino acid aminotransferase. , 2013, Enzyme and microbial technology.

[53]  A. A. Spector,et al.  Long chain fatty acid binding to human plasma albumin. , 1975, The Journal of biological chemistry.